Abbott India

Market Cap: Mid Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE358A01014
NSEID: ABBOTINDIA
BSEID: 500488
View on NSE | View on BSE

INR

27,410.00

130 (0.48%)

BSENSE

May 14

BSE+NSE Vol: 7.53 k

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Glenmark Pharma

Aurobindo Pharma

Laurus Labs

Ajanta Pharma

Ipca Labs

Biocon

J B Chemicals &

Anthem Bioscienc

Alkem Lab

Abbott India

Glaxosmi. Pharma

Why is Abbott India Ltd. ?

Flat results in Mar 26

NO KEY NEGATIVE TRIGGERS

With ROE of 38.7, it has a Very Expensive valuation with a 14.4 Price to Book Value

The stock is trading at a discount compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -9.53%, its profits have risen by 9.7% ; the PEG ratio of the company is 3.8

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Abbott India for you?

Low Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Abbott India

-9.61%

-0.43

22.19%

Sensex

-7.01%

-0.54

13.06%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

9.96%

EBIT Growth (5y)

16.04%

EBIT to Interest (avg)

90.03

Debt to EBITDA (avg)

0.11

Net Debt to Equity (avg)

-0.27

Sales to Capital Employed (avg)

1.65

Tax Ratio

25.36%

Dividend Payout Ratio

71.36%

Pledged Shares

Institutional Holding

9.20%

ROCE (avg)

156.19%

ROE (avg)

34.23%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

14.37

EV to EBIT

31.13

EV to EBITDA

29.88

EV to Capital Employed

19.40

EV to Sales

8.16

PEG Ratio

3.82

Dividend Yield

1.75%

ROCE (Latest)

59.65%

ROE (Latest)

38.70%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...